Review Article
Practical Approaches to the Use of Lenalidomide in Multiple Myeloma: A Canadian Consensus
Table 4
Lenalidomide dose adjustment for thrombocytopenia.
| Platelet count | Recommendations |
| <30 × 109/L on day 1 of a cycle | Delay start of the cycle for a week, until platelet count ≥30 × 109/L | <30 × 109/L during a cycle | Interruption of lenalidomide until next cycle (dexamethasone should be continued) | Returning to ≥30 × 109/L on next cycle | Reduce lenalidomide to the first reduction level | For each subsequent drop <30 × 109/L | Interrupt lenalidomide treatment | Returning to ≥30 × 109/L on next cycle | Resume lenalidomide at next dose reduction level |
|
|